abstract |
The present invention relates to novel monomaleimide-functionalized platinum compounds of formula (I), in particular including novel monomaleimide-functionalized oxaliplatin and carboplatin derivatives, and their use as pharmaceuticals, in particular for the treatment or prevention of cancer. . |